Phio Pharmaceuticals

PHIO on Nasdaq. Market value $9m.

Watch this stockFree. We tell you when something changes.

Should I look at this?

Look carefully before going further

Why it could be worth it

Nothing stands out yet.

Read the warning sign in its own filings

This is not advice.

Compare with another stock

Who owns it

None of the long-term investors we follow own it. 24 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

2 investors own more than 5%.

  • CVI Investments, Inc.
    Passive investor
    at least 9.9%0.0 pts
    (filed with 1 related holder)
    Since 30 September 2026
  • Mitchell P. Kopin
    Passive investor
    at least 9.1%+2.1 pts
    (filed with 2 related holders)
    Since 31 December 2025
  • Orca Capital AG
    Passive investor
    Sold down below 5%
    Since 8 December 2025

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 4 insiders bought $140,478 of shares on the open market.

Cluster buy3 insiders bought within 30 days (9 November 2026 to 13 November 2026).
  • Deming David H
    Director
    Bought
    Date
    13 November 2026
    Shares
    3,000
    Price
    $0.83
    Value
    $2,500
  • Deming David H
    Director
    Bought
    Date
    12 November 2026
    Shares
    9,000
    Price
    $0.81
    Value
    $7,322
  • Deming David H
    Director
    Bought
    Date
    11 November 2026
    Shares
    5,200
    Price
    $0.84
    Value
    $4,358
  • Deming David H
    Director
    Bought
    Date
    10 November 2026
    Shares
    6,800
    Price
    $0.84
    Value
    $5,709
  • Plott Ronald Todd
    Director
    Bought
    Date
    9 November 2026
    Shares
    18,300
    Price
    $0.83
    Value
    $15,189
  • Bitterman Robert J
    Chairman, Pres. & CEO, Director
    Bought
    Date
    9 November 2026
    Shares
    25,000
    Price
    $0.82
    Value
    $20,500
  • Plott Ronald Todd
    Director
    Bought
    Date
    29 September 2026
    Shares
    5,000
    Price
    $1.04
    Value
    $5,200
  • Plott Ronald Todd
    Director
    Bought
    Date
    28 September 2026
    Shares
    5,000
    Price
    $1.03
    Value
    $5,150
  • BRADFORD PATRICIA A
    Director
    Bought
    Date
    24 September 2026
    Shares
    6,500
    Price
    $1.01
    Value
    $6,583
  • Bitterman Robert J
    Chairman, Pres. & CEO, Director
    Bought
    Date
    22 September 2026
    Shares
    2,000
    Price
    $1.03
    Value
    $2,058

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

1 serious warning sign in Phio Pharmaceuticals’ filings.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 5 Mar 2026, plus the 10-Q filed 5 Nov 2026 and 10 later 8-Ks.

  • Doubt it can keep going

    Serious

    The company or its auditor warned it may not have enough money to last the next year.

    “These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”
    Show the full paragraph
    The Company has limited cash resources, has reported recurring losses from operations since inception, has negative operating cash flows and has not yet generated product revenues. As of September 30, 2026, the Company had cash and cash equivalents of approximately $ 10.6 million. These factors raise substantial doubt regarding the Company's ability to continue as a going concern. Based on the Company's current operating plan and existing cash resources, management believes the Company may not have sufficient cash and cash equivalents to fund planned operations for at least the next 12 months from the date these condensed consolidated financial statements are released. The continuation of the Company as a going concern depends upon the Company’s ability to raise additional capital through an equity offering, debt offering and/or strategic opportunity to fund its operations. There can be no assurance that the Company will be successful in accomplishing these plans in order to continue as a going concern. These condensed consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

    From the 10-Q filed 5 November 2026, Part I, Item 1. Financial Statements. Read it in the filing

  • Changed auditor

    Worth knowing

    The company changed its auditor (the firm that checks its books) in the last two years.

    “As a result of this process, on April 17, 2025, the Audit Committee approved the dismissal of BDO USA, P.C. (“BDO”) as the Company’s independent registered public accounting firm, effective immediately.”

    From an 8-K filed 22 April 2025: Change of auditor. Read it in the filing

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.